Canna River CBD Tinctures, Gummies, Softgels and Kratom Review: Nobody Sells CBD This Cheaply Per Milligram — And Nobody Else Has Two Federal Deadlines Running At Once

Product Overview

The first thing to know is that the brand you are clicking through to has changed name. On 7 August 2026 every page on cannariver.com returned a 301 permanent redirect to riverbotanicals.com, whose title reads 'Home to Canna River, Kratom River, and more.' Canna River is now a product line inside a parent brand, River Botanicals, that also operates Kratom River. Nothing about that is improper — but if you expect to land on Canna River and arrive somewhere called River Botanicals, that is why.

The company itself is Canna River, LLC, of Newbury Park, California. The BBB records it as trading since 29 August 2016 — nine years, which is a long run in a category full of two-year-old brands — and gives it an A+ rating, though it is not BBB accredited.

The current catalogue runs to 31 items. CBD dominates: Classic, Calm, Pain and Sleep tinctures in standard and Ultra strengths, four gummy lines, four softgel lines, body balm and lotion, and pet tinctures and treats. There are four intoxicating hemp products — D8 Gummies, D8 Tincture, D9 Gummies and a D9 Drink Mix. And there is a kratom range: gummies, tablets and shots, some combined with kava.

The second change since the affiliate materials were written: the vape line is gone. The brief for this programme lists HHC cartridges, HHC disposables, D8 cartridges and D8 disposables as linkable products. On 7 August 2026 the vapes collection returned zero products and each of those product URLs failed to resolve. We cannot tell you why — the coming federal ban on synthetic cannabinoids, state vape restrictions and ordinary commercial decisions would all produce the same result — but if you came here for a Blue Dream HHC cartridge, it is no longer sold.

What remains is, on the numbers, exceptional value. Canna River publishes the exact cannabinoid content of every variant in the variant name itself, so you know before you click that the $35 Sleep Gummies are 50mg CBD plus 50mg CBN per gummy across 30 gummies. Most of this category makes you hunt through a certificate of analysis to learn that. Here it is on the label.

Ingredients & Amounts

Credit where it is due: this is the clearest potency labelling we have seen in this category. Every variant name states the exact cannabinoid content and count — '50mg CBD + 50mg CBN / 30 Gummies' — so you know what you are buying before you open the product page, let alone the certificate of analysis. Competitors routinely sell a '$29.99 gummy jar' without telling you whether each piece contains 10mg or 50mg. On price per milligram Canna River is in a different league from the rest of this market: the 6,000mg Classic tincture at $60 works out at a cent per milligram, and the 20,000mg Ultra at $100 at half that. If you use CBD regularly and have been paying $60 for a 1,000mg bottle elsewhere, that difference is real and worth acting on. Verify the certificate of analysis for your batch anyway — with potency this high, confirming the label is the point.

What the Manufacturer Claims

Canna River's marketing is notably restrained — 'hemp wellness redefined' is close to the whole of it, and we found none of the therapeutic overreach common in this category. It does not claim to treat anxiety, pain or insomnia, and it does not dress up its cannabinoid blends with clinical language. The naming does gesture at effects — 'Pain Gummies', 'Sleep Tincture', 'Calm Softgels' — which is how the whole category works, but it stops well short of a medical claim. The 60-day money-back guarantee is the claim with the most fine print attached, and we cover that below.

What the Science Actually Supports

CBD has one FDA-approved use: Epidiolex, a prescription drug for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome and tuberous sclerosis complex. That approval used specific doses in specific populations under medical supervision and tells you nothing about a wellness tincture.

For everyday consumer uses — sleep, anxiety, general pain — the evidence for CBD is thin and inconsistent. There are trials suggesting benefit for anxiety at doses far above what most consumer products deliver, and there is a large placebo response in this literature. It is fair to say some people find it helps; it is not fair to say it is proven to.

CBN, added to the sleep products, is widely marketed as sedating. The human evidence for that is very limited, and the reputation appears to rest more on marketing than on trials.

CBG and CBC, in the pain and topical formulas, have preclinical and preliminary work behind them and very little controlled human data.

Delta-8 and delta-9 THC are intoxicating, and that effect is well established. What is not established is safety data for the specific hemp-derived and often chemically converted forms sold at retail.

Kratom's alkaloids act on opioid receptors. The FDA has approved kratom for no medical use, and it has been associated with dependence, withdrawal and serious adverse events. Whatever people use it for, it should not be understood as a benign botanical.

Limits of That Evidence

Directions, Warnings & Allergens

Pricing, Subscription, Refunds & Shipping

Pros & Cons

Who It May Be Best For

• •Regular CBD users who have been overpaying elsewhere — the price per milligram here is genuinely hard to beat
• •Anyone who wants to know exactly how many milligrams they are taking without hunting through a lab report
• •People who are drug tested and need reliable broad-spectrum, THC-free options
• •Buyers who want CBN, CBG or CBC blends without a premium price
• •Anyone buying CBD rather than the intoxicating or kratom lines, which carry the regulatory risk

Who Should Avoid It

• •You are pregnant, breastfeeding, or under 21
• •You are drug tested and would be tempted by the full-spectrum or THC products
• •You take blood thinners or other medication with liver-metabolism interactions, without checking with a pharmacist first
• •You have any liver condition — particularly relevant to the kava-containing products
• •You have a history of substance dependence, in which case the kratom line is not for you
• •You live in a state where kratom is banned, or where hemp THC products are restricted
• •You are looking for treatment for a diagnosed condition — none of this is approved for any medical use
• •You want to stock up on delta-8 or delta-9 products, given the 12 November 2026 deadline

Alternatives

Frequently Asked Questions

Our Take

On the thing most CBD buyers actually care about, Canna River wins outright. Six thousand milligrams of CBD for $60, or twenty thousand for $100, is roughly a tenth of what much of this market charges, and every variant tells you its exact cannabinoid content before you click into it. After reviewing a long run of brands that hide milligrams behind a certificate of analysis and charge $60 for a 1,000mg bottle, that combination of transparency and price is genuinely refreshing. Nine years of trading and an A+ BBB rating support it.

Three changes have happened since this brand's affiliate materials were written, and a buyer should know all of them. Cannariver.com now redirects wholly to River Botanicals, so the name on the site will not be the name you clicked. The entire vape line has gone — every HHC and disposable product in those materials fails to resolve. And a kratom range has arrived, which is a different category of product with a different risk profile entirely.

Two federal clocks are running. Section 781 takes effect on 12 November 2026 and, on the face of the statute, ends lawful sale of the delta-8 and delta-9 products in their current form — the D9 gummies alone carry roughly 300mg of THC per container against a new 0.4mg cap. And the DEA began temporary scheduling proceedings for concentrated 7-OH on 1 July 2026, with FDA warning letters already issued over products in the same formats as the kratom line here. Neither means Canna River is doing anything unlawful today. Both mean you should not stock up.

The weaker points are ordinary rather than alarming: certificates published through a Dropbox folder instead of a batch lookup, a 60-day guarantee limited to first-time single-product orders and granted at the company's sole discretion, and a paid shipping add-on to watch for at checkout.

We rate Canna River 3.7 out of 5 — outstanding value and labelling in its CBD range, marked down for a rebrand its own materials have not caught up with, a guarantee that is discretionary, and two product lines sitting in front of federal deadlines.

Buy the CBD, which is where the value is and where the regulatory risk is not. Buy one product first and confirm the certificate for your batch. Leave the delta-8 and delta-9 lines alone unless you want them for the next three months only, and approach the kratom range as you would any substance that acts on opioid receptors — which is to say, carefully, legally, and not at all if you have a history of dependence.